Pernix Therapeutics Holdings Inc (PTXTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,141 | -169,590 | -148,315 | -35,286 | -25,635 |
| Depreciation Amortization | 81,910 | 92,712 | 99,711 | 35,332 | 9,971 |
| Income taxes - deferred | -238 | -200 | 6,746 | -11,753 | -22,516 |
| Accounts receivable | 5,412 | 11,009 | -17,082 | -18,480 | 12,163 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 12,161 | -3,398 |
| Other Working Capital | -3,501 | 22,268 | -4,238 | 10,483 | 21,847 |
| Other Operating Activity | -12,381 | 27,300 | 48,429 | 16,439 | 1,037 |
| Operating Cash Flow | $-5,939 | $-16,501 | $-14,749 | $8,896 | $-6,531 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -984 | -1,212 | -1,134 | -497 |
| Net Acquisitions | N/A | -583 | -87,986 | -253,813 | -310 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 4,605 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 175 | 19,588 |
| Other Investing Activity | 2,000 | 0 | 4,850 | 5,025 | 19,588 |
| Investing Cash Flow | $1,982 | $-1,567 | $-84,348 | $-249,922 | $23,386 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 185 | -1,000 | 7,655 | N/A | N/A |
| Debt Issued | 30,000 | N/A | 130,000 | 285,000 | N/A |
| Debt Repayment | -18,063 | -20,483 | -10,057 | -46 | -144 |
| Common Stock Issued | 1,979 | 19,814 | 395 | 2,149 | 262 |
| Other Financing Activity | -13,699 | -23 | -7,616 | -26,869 | -24,349 |
| Financing Cash Flow | $402 | $-1,692 | $120,377 | $260,234 | $-24,231 |
| Beginning Cash Position | 36,375 | 56,135 | 34,855 | 15,647 | 23,023 |
| End Cash Position | 32,820 | 36,375 | 56,135 | 34,855 | 15,647 |
| Net Cash Flow | $-3,555 | $-19,760 | $21,280 | $19,208 | $-7,376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,939 | -16,501 | -14,749 | 8,896 | -6,531 |
| Capital Expenditure | -18 | -984 | -1,212 | -1,177 | -528 |
| Free Cash Flow | -5,957 | -17,485 | -15,961 | 7,719 | -7,059 |